Navigation Links
FDA Approves Lamictal®XR™ (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients
Date:4/25/2011

nstrual pattern, such as breakthrough bleeding, while taking Lamictal XR and birth control pills. These are not all the possible side effects of Lamictal XR. For more information, patients should ask their healthcare provider or pharmacist.

For more information about Lamictal XR please see the full Prescribing Information, including Boxed Warning at www.gsk.com.

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information go to us.gsk.com, follow us on twitter.com/GSKUS or visit our blog (www.morethanmedicine.us.gsk.com/blog/).  

*Depakene and Depakote are registered trademarks of Abbott Laboratories.Cautionary statement regarding forward-looking statementsUnder the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2010.Registered in England & Wales:No. 3888792Registered Office:980 Great West Road

Brentford, Middlesex

TW8 9GS
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves the First Vaccine to Prevent Meningococcal Disease in Infants and Toddlers
2. FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis
3. FDA Approves New Medical Device for Form of Brain Cancer
4. FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors
5. FDA Approves Horizant To Treat Restless Legs Syndrome
6. FDA Approves New Treatment for Rare Form of Thyroid Cancer
7. FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Groups Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
8. FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
9. FDA Approves New Treatment for a Type of Late-Stage Skin Cancer
10. FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age
11. FDA Approves Gadavist for Central Nervous System Scans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Reportlinker.com announces ... in its catalogue: mHealth and Home ... http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-6th-Edition.html Executive summary ... leading to better outcomes, decreased costs and improved ... mHealth solutions is still in an early stage, ...
(Date:7/30/2014)... , July 30, 2014   Unique Pizza ... Inc.: OTC Pink: UPZS), a Delaware Corporation, is ... agreement with Larasan Pharmaceutical Corporation ("Larasan"), a nature-based pharmaceutical ... to the agreement, US-based Larasan will work with ... frozen pizza through Larasan,s vast distribution network throughout ...
(Date:7/30/2014)... Cynosure, Inc. (NASDAQ: CYNO ... non-invasive and minimally invasive applications, today announced that the Board ... and Chief Financial Officer Timothy W. Baker to ... will continue to serve as CFO and will take the ... Chairman and Chief Executive Officer. "Tim has ...
Breaking Medicine Technology:mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2
... July 13, 2011 The U.S. Food and Drug ... care providers and patients that surgical placement of mesh ... expose patients to greater risk than other surgical options. ... The safety communication also says that with the exposure ...
... 2011 When flu season arrives this fall, a ... medication—will be available in a new, lower concentration to ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The change applies ... is a powder form of the prescription medication that ...
Cached Medicine Technology:FDA: Surgical Placement of Mesh to Repair Pelvic Organ Prolapse Poses Risks 2FDA: Surgical Placement of Mesh to Repair Pelvic Organ Prolapse Poses Risks 3FDA: Surgical Placement of Mesh to Repair Pelvic Organ Prolapse Poses Risks 4FDA CONSUMER HEALTH INFORMATION - Concentration Lowered in Tamiflu Medication 2
(Date:7/30/2014)... -- Some obese people have a genetic mutation that ... brains when they see food, researchers report. Gaining ... of pleasure and gratification at the sight of high-calorie ... prevent overeating, the scientists suggested. More than one-third ... caused by a combination of overeating, a lack of ...
(Date:7/30/2014)... July 30, 2014. A new network of 25 regional ... Trials Network (NIH StrokeNet) is working to change ... Despite advances of the last two decades, stroke ... causes death or disability for 795,000 Americans. The numbers ... the population. , To accelerate the pace of ...
(Date:7/30/2014)... The Ehlers-Danlos National Foundation (EDNF) is pleased to ... will serve as chair. The board was voted upon ... Conference in Houston, Texas July 10-12. , “The ... us. From the rollout of the first EDNF Center ... Medical Center to our September physicians conference to a ...
(Date:7/30/2014)... July 30, 2014 As the controversy ... in gynecological surgeries continues to grow, Bernstein Liebhard LLP ... those calling for a ban on uterine morcellation. According ... was diagnosed with leiomyosarcoma following a hysterectomy that involved ... of her diagnosis, the aggressive cancer had progressed to ...
(Date:7/30/2014)... 30, 2014 Hospitals continually face ... of care that their practitioners provide. During a ... Rowe, discussed the importance of establishing effective peer ... performance and quality of care. , With ... Mr. Rowe elaborated on setting performance expectations, conducting ...
Breaking Medicine News(10 mins):Health News:Gene Mutation May Make Food More Tempting 2Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:Ehlers-Danlos National Foundation Announces New Leadership 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 4Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3
... , BUFFALO, N.Y., July 15 CTG (Nasdaq: ... company, announced today that it was named by Healthcare Informatics ... providers, the Healthcare Informatics 100 (HCI 100). CTG was named to ... healthcare provider market. In addition to other large healthcare IT consulting ...
... , , DALLAS, ... Enterprises, LLC announced today that the company has been awarded ... Medicaid Services (CMS) to serve as the Medicare Administrative Contractor ... The full period of contract performance is five years, including ...
... WOODCLIFF LAKE, N.J., July 15 Par Pharmaceutical Companies, Inc. (NYSE: ... live webcast on Tuesday, August 4, 2009 at 9:00 am EDT to review ... its financial results on August 4 before the market opens. The earnings release ... , , Access to the live webcast can ...
... , , NAPLES, Fla., July 15 ... parents, has gathered the top ten issues that affect caregivers. These issues ... ( www.agingcare.com/Community ), where caregivers connect and communicate with one ... paid for caregiving. Oftentimes, adult children have to give up their ...
... July 15 The overall OTC market grew 3.2% during non-recession ... Impact of Recessions on the U.S. OTC Market ... , The impact of recessions on ... by private-label products and is reflected in slower growth rates. The ...
... the way for future targeted treatment, , WEDNESDAY, July ... cells appear to be important predictors of the spread ... measured levels of circulating endothelial cells and endothelial progenitor ... with metastatic cancer and 20 healthy children. Circulating endothelial ...
Cached Medicine News:Health News:CTG Named to Healthcare Informatics Annual Ranking of the Top 100 Healthcare IT Providers 2Health News:CTG Named to Healthcare Informatics Annual Ranking of the Top 100 Healthcare IT Providers 3Health News:CMS Selects TrailBlazer Health Enterprises to Administer Medicare Program in Arkansas, Louisiana and Mississippi 2Health News:Caring for Elderly Parents Is Tougher During Hard Times 2Health News:OTC Market Is Not Largely Impacted by Recession; However, Prominent Growth Remains Only in Some Categories, According to Kline 2Health News:Rare Cells Linked to Pediatric Cancers 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: